Anaemia and enhancement of coagulation are associated with severe COVID-19 infection

References

• Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54–67.
   PubMed Web of Science ®Google Scholar
• Iba T, Warkentin TE, Thachil J, et al. Proposal of the definition for COVID-19-Associated coagulopathy. JCM. 2021;10(2):191.
   Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH, Levi M, et al. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–2109.
   PubMed Web of Science ®Google Scholar
• Toh CH, Hoots WK. The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the international society on thrombosis and haemostasis: a 5-year overview. J Thromb Haemost. 2007;5(3):604–606.
   PubMed Web of Science ®Google Scholar
• Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647.
   PubMed Web of Science ®Google Scholar
• Taneri PE, Gomez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763–773.
   PubMed Web of Science ®Google Scholar
• Dinkla S, van Eijk LT, Fuchs B, et al. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane. BBA Clin. 2016;5:186–192.
   PubMedGoogle Scholar
• Finnish Institute for Health and Welfare. [Internet]. Helsinki: Finnish Institute for Health and Welfare [cited 2021 Oct 13] Available from: https://thl.fi/en/web/thlfi-en.
   Google Scholar
• Eisele L, Durig J, Broecker-Preuss M, et al. Prevalence and incidence of anemia in the German Heinz Nixdorf recall study. Ann Hematol. 2013;92(6):731–737.
   PubMed Web of Science ®Google Scholar
• Weisel JW, Litvinov RI. Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemost. 2019;17(2):271–282.
   PubMed Web of Science ®Google Scholar
• Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50.
   PubMed Web of Science ®Google Scholar
• Kabat GC, Kim MY, Verma AK, et al. Association of hemoglobin concentration with total and cause-specific mortality in a cohort of postmenopausal women. Am J Epidemiol. 2016;183(10):911–919.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Yufei Y, Mingli L, Xuejiao L, et al. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19). Scand J Clin Lab Invest. 2020;80(7):536–540.
   PubMed Web of Science ®Google Scholar
• Benoit JL, Benoit SW, Oliveira MD, et al. Anemia and COVID-19: a prospective perspective. J Med Virol. 2021;93(2):708–711.
   PubMed Web of Science ®Google Scholar
• Tao Z, Xu J, Chen W, et al. Anemia is associated with severe illness in COVID-19: a retrospective cohort study. J Med Virol. 2021;93(3):1478–1488.
   PubMed Web of Science ®Google Scholar
• Tremblay D, Rapp JL, Alpert N, et al. Mild anemia as a single independent predictor of mortality in patients with COVID‐19. EJHaem. 2021;2(3):319–326. https://doi.org/10.1002/jha2.167 Online ahead of print
   PubMedGoogle Scholar
• Whelihan MF, Mann KG. The role of the red cell membrane in thrombin generation. Thromb Res. 2013;131(5):377–382.
   PubMed Web of Science ®Google Scholar
• Walton BL, Byrnes JR, Wolberg AS. Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost. 2015;13:S208–S215.
   PubMed Web of Science ®Google Scholar
• Wohner N, Sotonyi P, Machovich R, et al. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol. 2011;31(10):2306–2313.
   PubMed Web of Science ®Google Scholar
• Kempe DS, Akel A, Lang PA, et al. Suicidal erythrocyte death in sepsis. J Mol Med. 2007;85(3):273–281.
   PubMed Web of Science ®Google Scholar
• Sran K, Olsburgh J, Kasimatis T, et al. COVID-19 in kidney transplant patients from a large UK transplant center: exploring risk factors for disease severity. Transplant Proc. 2021;53(4):1160–1168.
   PubMed Web of Science ®Google Scholar
• Akhter N, Ahmad S, Alzahrani FA, et al. Impact of COVID-19 on the cerebrovascular system and the prevention of RBC lysis. Eur Rev Med Pharmacol Sci. 2020;24(19):10267–10278.
   PubMed Web of Science ®Google Scholar
• Gong J, Ou J, Qiu X, et al. A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020;71(15):833–840.
   PubMed Web of Science ®Google Scholar
• Thangaraju K, Neerukonda SN, Katneni U, et al. Extracellular vesicles from red blood cells and their evolving roles in health, coagulopathy and therapy. Int J Mol Sci. 2020;22(1):153.
   PubMed Web of Science ®Google Scholar
• Melki I, Tessandier N, Zufferey A, et al. Platelet microvesicles in health and disease. Platelets. 2017;28(3):214–221.
   PubMed Web of Science ®Google Scholar
• Alnor A, Sandberg MB, Toftanes BE, et al. Platelet parameters and leukocyte morphology is altered in COVID-19 patients compared to non-COVID-19 patients with similar symptomatology. Scand J Clin Lab Invest. 2021;81(3):213–217.
   PubMed Web of Science ®Google Scholar
• Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets. 2020;31(6):740–745.
   PubMed Web of Science ®Google Scholar
• Sjöström A, Wersäll J, Warnqvist A, et al. Platelet count rose while D-Dimer levels dropped as deaths and thrombosis declined-an observational study on anticoagulation shift in COVID-19. Thromb Haemost. 2021; Apr 8. doi:https://doi.org/10.1055/a-1477-3829. Online ahead of print.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Laukkanen JA. Incidence of venous and arterial thromboembolic complications in COVID-19: a systematic review and meta-analysis. Thromb Res. 2020;196:27–30.
   PubMed Web of Science ®Google Scholar
• Trimaille A, Thachil J, Marchandot B, et al. D-Dimers level as a possible marker of extravascular fibrinolysis in COVID-19 patients. JCM. 2020;10(1):39.
   Web of Science ®Google Scholar
• Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489–500.
   PubMed Web of Science ®Google Scholar
• Semeraro F, Colucci M, Caironi P, et al. Platelet drop and fibrinolytic shutdown in patients with sepsis. Crit Care Med. 2018;46(3):e221–e228.
   PubMed Web of Science ®Google Scholar
• Semeraro F, Ammollo CT, Caironi P, et al. Low D-dimer levels in sepsis: good or bad? Thromb Res. 2019;174:13–15.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Warnock M, Harbaugh A, et al. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci Rep. 2021;11(1):1580.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847.
   PubMed Web of Science ®Google Scholar
• Rauch A, Labreuche J, Lassalle F, et al. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. J Thromb Haemost. 2020;18(11):2942–2953.
   PubMed Web of Science ®Google Scholar
• Shovlin CL, Angus G, Manning RA, Okoli GN, et al. Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertension. PLoS One. 2010;5(2):e9154.
   PubMedGoogle Scholar
• Finnish national update on ICU care on COVID [Internet]. Kuopio: Kuopio University Hospital; 2021 [cited Oct 13]. Available from: https://www.psshp.fi/documents/7796350/7841067/Tehohoidon+tilannekuva+02062021/ca3ff1b6-d41c-43d1-ad01-310630e42162
   Google Scholar
• Reinikainen M, Varpula T. [Finnish ICU-care]. Duodecim. 2018;134:161–163. Finnish.
   Google Scholar